Recovery timeline: Week 1: Surgical shoe or boot, weight-bearing as tolerated with a limp, elevation and ice Week 2: Transition to athletic shoes, most patients back to desk jobs Weeks 3 to 6: Progressive activity, physical therapy begins, back to light-duty work Months 2 to 3: Full activity clearance, gradually resume running and sports Full recovery: 3 to 4 months Success rate: 85 to 90% achieve good-to-excellent outcomes
For example, in tendon fibroblast cells, BPC-157 dramatically increases phosphorylation (activation) of FAK and paxillin, leading to more cell migration and survival at injury sites
The difference lies in how these compounds bind to plasma proteins and are stored in the liver
Reconstitution note: Tesamorelin is strongly cationic and prone to injection-site welts, so reconstitute with 0.9% NaCl bacteriostatic water rather than plain BAC water the sodium and chloride ions screen the peptides charge and shrink the welt
Design of the TRIUMPH Phase 3 program
AOD-9604 vs GLP-1 S GLP-1 S (semaglutide) works through an entirely different system than AOD-9604: it activates GLP-1 receptors to slow gastric emptying, increase satiety, and improve glycemic control, producing weight loss primarily by reducing food intake rather than by acting on fat cells directly